Government Blinks Again on Obamacare By Megan McArdle

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
Government Blinks Again on Obamacare

By Megan McArdle
Feb 2, 2015 2:34 PM EST

If you got health insurance subsidies last year, and you're worried that you got too much in federal tax credits and will be faced with a huge tax bill for repayment, then you can worry a little less: The IRS says that people who are liable for repayment ("clawback" of excess subsidies won't have to pay by April 15.

It's not relieving you of the obligation to repay; it's just saying that you won't be liable for a penalty if you don't repay by the deadline. Interest will continue to accrue, but the interest rates that the IRS charges are actually pretty reasonable (and probably much better than what your credit card company charges). It's the failure-to-pay penalties it layers on top -- half a percentage point a month, with even stiffer penalties for failing to file -- that really make your tax bill add up fast.

The IRS emphasizes that this is a one-time-only deal, just for 2014. But I'm not sure if you should believe that. This emphasizes one of the problems we've spoken about a lot in this space: The political will to impose the costs of the Affordable Care Act is a lot less strong than the will to distribute the benefits.

At every turn, when it has come time to actually make people bear the price, the government has blinked. The employer mandate was delayed, cuts to Medicare Advantage were delayed, deadlines to purchase insurance were pushed back, and now the need to repay excess subsidies has been eased. Remember, these payments were increased just a few years back in order to pay for the repeal of a different, unworkable part of the bill: the provision that would have required people to issue 1099s to anyone who sold them more than $600 worth of stuff.

But the political logic is inescapable: A bunch of people are about to find out that they got too much in subsidies, and now they owe the IRS hundreds, possibly even thousands, of dollars. Many of those people won't have the money, and they are about to get very upset. So the Barack Obama administration did what it has done before: nursed the program forward with administrative rulings that minimize the political blowback. Presumably the idea is that by the time it actually lets the cost side take effect, so many people will be getting subsidies that it will be effectively impossible to repeal.

Some of the "nursing" measures they might be tempted to take are existential threats to the bill, such as easing off the individual mandate. But this, like most of what it has already done, does not threaten Obamacare's viability as a system. What it does renege on is the promise that the bill would be deficit-neutral -- even deficit-reducing! What it does is raise the cost of a program that was sold on the promise that it would reduce costs.

Though the Congressional Budget Office has stopped scoring it, after all these changes, I find it hard to believe that Obamacare is now deficit-neutral, much less deficit-reducing. Of course, temporary transitional relief is not that expensive; it's just a year of revenue. But it's not going to get easier to impose these costs going forward. If anything, it will get harder, because people will be used to things the way they are. Moreover, costs imposed in year one would be at least partially offset by the new benefits, in terms of premium subsidies. Costs imposed in years two to infinity will not be viewed as the unfortunate costs of getting new benefits; they'll just be seen as new costs that those who pay will very much resent. I would be very surprised indeed if the administration suddenly rediscovered its backbone in 2016, with its party staring down an election in which Obamacare will very much be an issue. And even more surprised if a future administration decided to be the party pooper that cracked down on costs after the Obama administration got to be the one handing out the goodies.

There is one possible piece of counter-evidence to my thesis: the employer mandate, which the administration did finally impose on large employers after a year delay. And yet, I don't think this is much of a counterweight. The 2015 version of the employer mandate is so weak that it's effectively not that much different from no mandate, as almost all large firms already offer their employees health insurance. Symbolically, the mandate still exists; practically, it doesn't, until the government really does demand 95 percent coverage from all companies with more than 50 employees.

This ruling by itself is not a particularly big deal -- it's just delaying the repayment of what people owe, not forgiving it. Presumably there's some permanent loss of the income that would normally have been expected, but the gears of the government will not therefore grind to a halt. But it is important as a symptom of a broader tendency in the administration, to be free with the spending and not so free collecting the revenue needed to pay for it. As I say, this is not in any way an existential threat to the program. It's just a creeping leak in the taxpayer's wallet.

To contact the author on this story:
Megan McArdle at mmcardle3@bloomberg.net

http://www.bloombergview.com/articles/2015-02...cmpid=yhoo
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 166

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 125

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 121

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 180

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 133

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
Datavault AI's Turbulent Boardroom Saga Escalates

Updated Category News Views 201

The Corporate Chess Game at Datavault AI If there's one thing Wall Street hates, it's uncertainty. And boy, does Datavault AI (NASDAQ: DVLT) deliver plenty of it right now. Founder Nathaniel Bradley has lobbed a lawsuit at the board, claiming that Chairman and CFO Brett Moyer orchestrated a coup to oust him without proper board procedures. Talk about drama fit for a soap...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 143

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 122

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 168

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Highlights of Week 17: Progress Under Trump’s Leadership

Updated Category News Views 424

Key Achievements in Week 17 Under Trump’s Leadership The recent developments from the Trump Administration have brought significant changes that resonate deeply with many Americans. Week 17 showcased not only triumph but also transformative strategies aimed at improving the lives of citizens. A notable highlight this week was President Trump's Executive Order focused on...

Continue Reading
Philips Shareholder Meeting Yields Positive Leadership Decisions

Updated Category News Views 359

Philips Shareholder Meeting: Key Outcomes from the AGM On a significant day for Royal Philips, shareholders gathered to approve a series of pivotal resolutions during the Annual General Meeting of Shareholders (AGM). The meeting highlighted a robust commitment to enhancing leadership structure and governance, reflecting the company’s dedication to ongoing improvement in...

Continue Reading
Growing Trends in the Lawn and Garden Consumables Market

Updated Category News Views 197

Overview of the Lawn and Garden Consumables Market The Lawn and Garden Consumables market is poised for significant growth, with a future projected value of approximately USD 38 billion by 2034. This sector includes essential products like fertilizers, seeds, pesticides, and more, serving various end-users from residential to commercial and industrial landscapes. Current...

Continue Reading
Weyerhaeuser Set for Q2 Earnings Release July 30

Updated Category News Views 59

Building Up to the Big Reveal There's always a buzz ahead of Weyerhaeuser's earnings releases, and this one's no different. On July 30, they're set to drop the curtain on their second quarter results for 2026. Now, you'd think that's standard fare, but when you've got a giant like Weyerhaeuser (NYSE: WY) on the table, investors sit up straight. With over 10 million acres...

Continue Reading
FINBOA Honored for Innovative Compliance Solutions at PayTech Awards

Updated Category News Views 178

FINBOA Celebrated for Excellence in Payments Compliance FINBOA, a front-runner in payments dispute automation and regulatory compliance, has been recognized as a finalist for the prestigious 2025 PayTech USA Awards. This nomination is for the category of Best Regulations & Compliance in Payments Solution, demonstrating the company’s commitment to innovation and...

Continue Reading